G-pen may aid hypoglycemia with type 1 diabetes

February 22, 2016

(HealthDay)—Mini-dose glucagon administered using a stable, ready-to-use G-Pen Mini glucagon may be an effective option for mild to moderate hypoglycemia in adults with type 1 diabetes, according to a study published online Feb. 9 in Diabetes Care.

Morey W. Haymond, M.D., from the Baylor College of Medicine in Houston, and colleagues evaluated mini-dose glucagon in 12 adults with type 1 using a stable, liquid, ready-to-use preparation. Subcutaneous doses of 75, 150, and 300 µg of nonaqueous glucagon were administered and, at 180 minutes, subjects received insulin, followed in 60 minutes by a second identical dose of glucagon.

The researchers found that for the 75-, 150-, and 300-µg doses, mean (fasting glucose concentrations [mg/dL] were 110, 110, and 109, respectively, increasing maximally at 60 minutes by 33, 64, and 95 mg/dL [all P < 0.001]). The administered post-insulin were 70, 74, and 70 mg/dL, respectively, with maximal increases of 19, 24, and 43 mg/dL post-glucagon administration (P < 0.02) at 45 to 60 minutes.

"Subcutaneous, nonaqueous, ready-to-use G-Pen Mini glucagon may provide an alternative to oral carbohydrates for the management of anticipated, impending, or mild hypoglycemia in adults with type 1 diabetes," the authors write.

Several authors disclosed financial ties to Xeris Pharmaceuticals, the maker of the G-Pen.

Explore further: Protein preload boosts vildagliptin's effects in diabetes

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Protein preload boosts vildagliptin's effects in diabetes

February 3, 2016
(HealthDay)—A protein preload enhances the glucose-lowering efficacy of vildagliptin in type 2 diabetes, according to a study published online Jan. 19 in Diabetes Care.

Artificial sweeteners produce no glucagon response

January 14, 2014
(HealthDay)—Artificial sweeteners do not produce any changes in glucose metabolism compared to a glass of water, according to a letter published in the December issue of Diabetes Care.

Early loss of glucagon response to hypoglycemia found in teens

June 22, 2012
(HealthDay) -- In adolescents with type 1 diabetes the glucagon response to hypoglycemia is lost as early as one month and at a median of eight months after diabetes diagnosis, according to a study published online June 14 ...

Glucagon, GLP-1 co-infusion can reduce appetite

June 25, 2014
(HealthDay)—Co-infusion of glucagon and glucagon-like peptide 1 (GLP-1) correlates with a reduction in appetite, and GLP-1 protects against glucagon-induced hyperglycemia in healthy volunteers, according to a study published ...

Glucose levels linked to cardiac surgery outcomes

January 23, 2016
(HealthDay)—For patients undergoing cardiac surgery, hyperglycemia is associated with worse outcomes for patients without diabetes, but with better outcomes for patients with insulin-treated diabetes, according to a study ...

Dextromethorphan plus sitagliptin promising in type 2 diabetes

September 21, 2015
(HealthDay)—Dextromethorphan combined with sitagliptin shows potential for treatment of type 2 diabetes mellitus, according to a study published online Sept. 12 in Diabetes, Obesity and Metabolism.

Recommended for you

Diabetes pill might replace injection to control blood sugar

October 17, 2017
(HealthDay)— An injectable class of diabetes medication—called glucagon-like peptide-1 or GLP-1—might one day be available in pill form, research suggests.

Skimping on sleep may contribute to gestational diabetes

October 17, 2017
The amount of time spent sleeping in the United States has dropped significantly in the past twenty years with almost a quarter of women and 16 percent of men experiencing insufficient sleep. Now, a new study has found that ...

Artificial pancreas performs well in clinical trial

October 16, 2017
During more than 60,000 hours of combined use of a novel artificial pancreas system, participants in a 12-week, multi-site clinical trial showed significant improvements in two key measures of well-being in people living ...

Omega-6 fats may help prevent type 2 diabetes

October 11, 2017
The risk of developing type 2 diabetes could be significantly reduced by eating a diet rich in omega-6 polyunsaturated fats, a new study suggests.

Where there's type 1 diabetes, celiac disease may follow

October 10, 2017
(HealthDay)—Parents of young children with type 1 diabetes need to be on the lookout for symptoms of another autoimmune condition—celiac disease, new research suggests.

Type 1 diabetes and the microbiota—MAIT cells as biomarkers and new therapeutic targets

October 10, 2017
Together with colleagues from AP-HP Necker–Enfants Malades Hospital in Paris, scientists from the Cochin Institute (CNRS / INSERM / Paris Descartes University) have discovered that the onset of type 1 diabetes is preceded ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.